Prognostic Role of Pretreatment Blood Neutrophil-to-Lymphocyte Ratio in Advanced Cancer Survivors: A Systematic Review and Meta-Analysis of 66 Cohort Studies

CAS OpenIR > 膜生物学国家重点实验室

	Prognostic Role of Pretreatment Blood Neutrophil-to-Lymphocyte Ratio in Advanced Cancer Survivors: A Systematic Review and Meta-Analysis of 66 Cohort Studies
发表期刊	Cancer Treatment Reviews
	2017
卷号	58 页码:1-13
	Zu-Bing Mei; Shi L(施璐); Bo Wang; Ji-Zhen Yang; Zhi-Hong Xiao; Pei-Xin Du; Qing-Ming Wang; Wei Yang
文献类型	期刊论文
条目标识符	http://ir.ioz.ac.cn/handle/000000/12699
专题	膜生物学国家重点实验室
推荐引用方式 GB/T 7714	Zu-Bing Mei,Shi L,Bo Wang,et al. Prognostic Role of Pretreatment Blood Neutrophil-to-Lymphocyte Ratio in Advanced Cancer Survivors: A Systematic Review and Meta-Analysis of 66 Cohort Studies[J]. Cancer Treatment Reviews,2017,58:1-13.
APA	Zu-Bing Mei.,施璐.,Bo Wang.,Ji-Zhen Yang.,Zhi-Hong Xiao.,...&Wei Yang.(2017).Prognostic Role of Pretreatment Blood Neutrophil-to-Lymphocyte Ratio in Advanced Cancer Survivors: A Systematic Review and Meta-Analysis of 66 Cohort Studies.Cancer Treatment Reviews,58,1-13.
MLA	Zu-Bing Mei,et al."Prognostic Role of Pretreatment Blood Neutrophil-to-Lymphocyte Ratio in Advanced Cancer Survivors: A Systematic Review and Meta-Analysis of 66 Cohort Studies".Cancer Treatment Reviews 58(2017):1-13.